Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

Publication | Open Access

DOI Full Paper Access

117

Citations

References

2007

Year

David S. Alberts, Pengfei Liu, Sharon P. Wilczynski, Mary C. Clouser, Ana Mariá López, David P. Michelin, Victor J. Lanzotti, Maurie Markman

Gynecologic Oncology

MedicineMetronomic TherapyGynecologyPathologyLiposomal DoxorubicinInitial Platinum-based ChemotherapyCancer TreatmentCarboplatin Versus CarboplatinOncologyRadiation OncologyGynecology OncologyOvarian Cancer